[7] [8] Whether retatrutide's molecular structure would present additional formulation challenges compared with semaglutide is not established in the published literature
[DOI] [PubMed] [Google Scholar] 152.Ridaura V.K., Faith J.J., Rey F.E., Cheng J., Duncan A.E., Kau A.L., Griffin N.W., Lombard V., Henrissat B., Bain J.R., et al
While data specific to GLP-1 RA discontinuation remain limited, a large-scale prospective study on weight cycling (mean age 63.6 years, at high risk of T2DM) reported that weight regain was typically characterized by an adverse shift in body composition, with FM returning to baseline levels while FFM declined by 1.50 kg (95% CI 0.662.35)
Your body needs fuel to support the stimulation process and to reduce the risk of OHSS (ovarian hyperstimulation syndrome)
A., Sergeeva, M